PTGES

Chr 9

prostaglandin E synthase

Also known as: MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, PP1294

The protein catalyzes the glutathione-dependent conversion of prostaglandin endoperoxide H2 to prostaglandin E2, serving as the terminal enzyme in the COX-2-mediated inflammatory pathway and playing a key role in inflammation, fever, and pain responses. Biallelic mutations cause autosomal recessive intellectual disability with seizures and spasticity. The gene shows moderate constraint against loss-of-function variants.

OMIMResearchSummary from UniProt
MultiplemechanismLOEUF 0.73
Clinical SummaryPTGES
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.71) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 30 VUS of 70 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.73LOEUF
pLI 0.713
Z-score 1.88
OE 0.00 (0.000.73)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint
1.31Z-score
OE missense 0.61 (0.490.77)
56 obs / 91.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.00 (0.000.73)
00.351.4
Missense OE0.61 (0.490.77)
00.61.4
Synonymous OE1.20
01.21.6
LoF obs/exp: 0 / 4.1Missense obs/exp: 56 / 91.1Syn Z: -1.04
DN
0.74top 25%
GOF
0.7028th %ile
LOF
0.3066th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

70 submitted variants in ClinVar

Classification Summary

Pathogenic31
Likely Pathogenic2
VUS30
Likely Benign3
Benign3
31
Pathogenic
2
Likely Pathogenic
30
VUS
3
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
31
0
31
Likely Pathogenic
0
0
2
0
2
VUS
0
16
14
0
30
Likely Benign
0
2
0
1
3
Benign
0
1
0
2
3
Total01947369

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PTGES · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →